文献速递技术与安全骨肌腹部MRCTPET

多参数全身磁共振成像结合扩散加权成像与ADC图识别实体瘤内脏和骨转移

Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
PubMed 文献 · Acad Radiol · 2018-04-04

研究纳入54名参与者(32名健康者、22例患者),用3T磁共振行全身扩散加权成像及T2加权成像并构建ADC图,以CT或PET-CT确认病灶数。多参数全身磁共振对转移灶检测敏感度达96%,骨转移灶ADC值及ADC比较正常骨显著升高,软组织转移灶ADC值及比较正常软组织降低。

要点

  • 多参数全身磁共振(含DWI与ADC图)对实体瘤转移灶检测敏感度达96%。
  • 骨转移灶ADC值及ADC比较正常骨显著升高,软组织转移灶则降低。
  • 全身磁共振扫描及设置总时间约45分钟。

核心结论

  • 多参数全身磁共振对乳腺癌、前列腺癌、胰腺癌和结直肠癌的骨与内脏转移分期可行,可个体化定制序列用于分期及治疗反应评估。

研究设计与样本

  • 研究纳入54名参与者(32名健康者、22例患者),使用3T磁共振扫描仪行全身扩散加权成像,采集轴位、矢状位或冠状位脂肪抑制T2加权、T1加权及DWI图像,总采集及设置时间约45分钟;转移灶经T2加权成像特征确认,病灶数由CT或PET-CT确定。

关键影像表现/征象

  • 骨转移灶ADC图值及ADC比较正常骨显著升高(P < .05)。
  • 软组织转移灶ADC图值及ADC比较正常软组织降低。

诊断标准与关键数值

  • 以CT或PET-CT确定的91个转移灶为参照,多参数全身磁共振检测转移灶敏感度为96%。
  • 骨转移与正常骨的ADC值及ADC比差异用配对t检验,P < .05为有统计学意义。

临床应用与阅片要点

  • 作者认为多参数全身磁共振可用于乳腺癌、前列腺癌、胰腺癌和结直肠癌的骨与内脏转移分期。
  • 作者提出全身磁共振可按患者定制个体化序列,用于分期及治疗反应评估。

局限性

  • CT或PET-CT检出91个转移灶,但遗漏1个前列腺复发灶。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The purpose of this study was to investigate the use of multiparametric, whole-body, diffusion-weighted imaging (WB-DWI) and apparent diffusion coefficient (ADC) maps with T2-weighted magnetic resonance imaging (MRI) at 3T for the detection and monitoring of metastatic disease in patients.

MATERIALS AND METHODS: Fifty-four participants (32 healthy subjects and 22 patients) were scanned with WB-DWI methods using a 3T MRI scanner. Axial, sagittal, or coronal fat-suppressed T2-weighted (T2WI), T1-weighted (T1WI), and DWI images were acquired. Total MRI acquisition and set-up time was approximately 45 minutes. Metastatic disease on MRI was confirmed based on T2WI characteristics. The number of lesions was established on computed tomography (CT) or positron emission tomography (PET-CT). Whole-body ADC maps and T2WI were constructed, and region-of-interests were drawn in normal and abnormal-appearing tissue for quantitative analysis. Statistical analysis was performed using a paired t tests and P < .05 was considered statistically significant.

RESULTS: There were 91 metastatic lesions detected from the CT or PET-CT with a missed recurrent lesion in the prostate. Multiparametric WB-MRI had excellent sensitivity (96%) for detection of metastatic lesions compared to CT. ADC map values and the ADC ratio in metastatic bone lesions were significantly increased (P < .05) compared to normal bone. In soft tissue, ADC map values and ratios in metastatic lesions were decreased compared to normal soft tissue.

CONCLUSION: We have demonstrated that multiparametric WB-MRI is feasible for oncologic staging to identify bony and visceral metastasis in breast, prostate, pancreatic, and colorectal cancers. WB-MRI can be tailored to fit the patient, such that an "individualized patient sequence" can be developed for a comprehensive evaluation for staging and response during treatment.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Jacobs MA, Macura KJ, Zaheer A, et al. Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors. Acad Radiol. 2018. PMID: 29627288. doi:10.1016/j.acra.2018.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。